Dr. Mike Strange is head of operations for diseases in the developing world at GlaxoSmithKline. He joined GSK in 1999 to work in the portfolio management team, and since then has worked in several positions, including R&D Strategy Director and Head of Business Operations in Global Clinical Development at GSK Vaccines in Belgium. Strange currently supervises initiatives like setting up GSK’s open lab and the Tres Cantos Open Lab Foundation in Madrid, as well as the Africa NCD Open Lab.